GHRL and obesity due to melanocortin 4 receptor deficiency: Ablation of ghrelin worsens obesity, insulin resistance and adipose inflammation induced by HFCS, indicating that ghrelin signaling is a key mediator of HFCS-related immunometabolic outcomes.